BioCentury | Feb 14, 2020
Finance

You say you want a Revolution? Oncology company is latest to post big gain after IPO

...million across Revolution Medicines’ three venture rounds. The firm was also the founding investor in Warp Drive Bio...
BioCentury | Jan 29, 2020
Company News

Decibel narrows discovery focus to inner ear regeneration, taps Reid as CEO

..."R&D Reboot" ). Prior to becoming an EIR at Third Rock, Reid was CEO of Warp Drive Bio Inc....
BioCentury | Jul 9, 2019
Finance

Revolution raises $100M to build out Ras pipeline, explore SHP-2 combos

...on the Ras pathway. The latter was aided by the acquisition of Ras programs from Warp Drive Bio Inc....
BioCentury | Feb 13, 2019
Financial News

Arch-backed HiberCell launches with over $60M to target dormant cancer cells

...president and CSO, and Mark Mulvihill, VP of chemistry and drug discovery. They come from Warp Drive Bio Inc....
BioCentury | Feb 9, 2019
Company News

Emerging company roundup: HiberCell, Orexia, TamRx

...company, which is developing therapies that prevent cancer relapse and metastasis, is led by former Warp Drive Bio Inc....
BioCentury | Feb 7, 2019
Financial News

Arch-backed HiberCell launches with over $60M to target dormant cancer cells

...president and CSO, and Mark Mulvihill, VP of chemistry and drug discovery. They come from Warp Drive Bio Inc....
BioCentury | Dec 20, 2018
Finance

Third Rock keeps its options open

...entire biotech. Third Rock’s aversion to build-to-buy models was the fallout from its deal with Warp Drive Bio Inc....
...Euronext:SAN), Paris, France Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Tokyo, Japan Tango Therapeutics Inc., Cambridge, Mass. Warp Drive Bio Inc....
BioCentury | Oct 19, 2018
Finance

Warp Drive’s winding road to Revolution

...winding through nearly seven years of shifting strategies and a delayed entry into the clinic, Warp Drive Bio Inc....
...programs. Third Rock’s stake in the companies is undisclosed. Virginia Li, Assistant Editor Revolution Medicines Inc. Sanofi Third Rock Ventures Warp Drive Bio Inc....
BioCentury | Oct 19, 2018
Company News

Revolution acquiring Warp Drive

...is expanding its cancer pipeline with the acquisition of another Third Rock Ventures portfolio company, Warp Drive Bio Inc....
...its Genome Mining platform. The deal is expected to close by the end of October. Warp Drive Bio Inc....
...Medicines Inc., Redwood City, Calif. Business: Cancer Virginia Li RMC-4630 F. Hoffmann-La Roche Ltd. GlaxoSmithKline plc Revolution Medicines Inc. Third Rock Ventures Warp Drive Bio Inc. Eukaryotic...
BioCentury | Oct 16, 2018
Company News

Revolution acquiring fellow Third Rock company Warp Drive

...is expanding its cancer pipeline with the acquisition of another Third Rock Ventures portfolio company, Warp Drive Bio Inc....
...The deal is expected to close by the end of October. Virginia Li RAS Revolution Medicines Inc. Third Rock Ventures Warp Drive Bio Inc. Src...
Items per page:
1 - 10 of 34
BioCentury | Feb 14, 2020
Finance

You say you want a Revolution? Oncology company is latest to post big gain after IPO

...million across Revolution Medicines’ three venture rounds. The firm was also the founding investor in Warp Drive Bio...
BioCentury | Jan 29, 2020
Company News

Decibel narrows discovery focus to inner ear regeneration, taps Reid as CEO

..."R&D Reboot" ). Prior to becoming an EIR at Third Rock, Reid was CEO of Warp Drive Bio Inc....
BioCentury | Jul 9, 2019
Finance

Revolution raises $100M to build out Ras pipeline, explore SHP-2 combos

...on the Ras pathway. The latter was aided by the acquisition of Ras programs from Warp Drive Bio Inc....
BioCentury | Feb 13, 2019
Financial News

Arch-backed HiberCell launches with over $60M to target dormant cancer cells

...president and CSO, and Mark Mulvihill, VP of chemistry and drug discovery. They come from Warp Drive Bio Inc....
BioCentury | Feb 9, 2019
Company News

Emerging company roundup: HiberCell, Orexia, TamRx

...company, which is developing therapies that prevent cancer relapse and metastasis, is led by former Warp Drive Bio Inc....
BioCentury | Feb 7, 2019
Financial News

Arch-backed HiberCell launches with over $60M to target dormant cancer cells

...president and CSO, and Mark Mulvihill, VP of chemistry and drug discovery. They come from Warp Drive Bio Inc....
BioCentury | Dec 20, 2018
Finance

Third Rock keeps its options open

...entire biotech. Third Rock’s aversion to build-to-buy models was the fallout from its deal with Warp Drive Bio Inc....
...Euronext:SAN), Paris, France Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Tokyo, Japan Tango Therapeutics Inc., Cambridge, Mass. Warp Drive Bio Inc....
BioCentury | Oct 19, 2018
Finance

Warp Drive’s winding road to Revolution

...winding through nearly seven years of shifting strategies and a delayed entry into the clinic, Warp Drive Bio Inc....
...programs. Third Rock’s stake in the companies is undisclosed. Virginia Li, Assistant Editor Revolution Medicines Inc. Sanofi Third Rock Ventures Warp Drive Bio Inc....
BioCentury | Oct 19, 2018
Company News

Revolution acquiring Warp Drive

...is expanding its cancer pipeline with the acquisition of another Third Rock Ventures portfolio company, Warp Drive Bio Inc....
...its Genome Mining platform. The deal is expected to close by the end of October. Warp Drive Bio Inc....
...Medicines Inc., Redwood City, Calif. Business: Cancer Virginia Li RMC-4630 F. Hoffmann-La Roche Ltd. GlaxoSmithKline plc Revolution Medicines Inc. Third Rock Ventures Warp Drive Bio Inc. Eukaryotic...
BioCentury | Oct 16, 2018
Company News

Revolution acquiring fellow Third Rock company Warp Drive

...is expanding its cancer pipeline with the acquisition of another Third Rock Ventures portfolio company, Warp Drive Bio Inc....
...The deal is expected to close by the end of October. Virginia Li RAS Revolution Medicines Inc. Third Rock Ventures Warp Drive Bio Inc. Src...
Items per page:
1 - 10 of 34